Search Results

Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator.

• Authors : Singh D; The Medicines Evaluation Unit, Centre for Respiratory and Allergy Medicine, University of Manchester, University Hospital of South Manchester NHS Foundation Trust, M23 9QZ, Manchester, UK. .; Balaguer V

Subjects: Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/*administration & dosage ; Bronchoconstriction/Bronchoconstriction/Bronchoconstriction/*drug effects ; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*administration & dosage

• Source: Respiratory research [Respir Res] 2020 Sep 09; Vol. 21 (Suppl 1), pp. 102. Date of Electronic Publication: 2020 Sep 09.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium:

Record details

Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilator.

• Authors : Jimenez E; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, 08020, Barcelona, Spain. .; Astbury C

Subjects: Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/*administration & dosage ; Asthma/Asthma/Asthma/*drug therapy ; Bronchoconstriction/Bronchoconstriction/Bronchoconstriction/*drug effects

• Source: Respiratory research [Respir Res] 2020 Sep 09; Vol. 21 (Suppl 1), pp. 211. Date of Electronic Publication: 2020 Sep 09.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium:

Record details

Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studies.

• Authors : Balaguer, Victor¹ (AUTHOR); Albayaty, Muna² (AUTHOR); Jimenez, Eulalia³ (AUTHOR)

• Source: Respiratory Research. 9/9/2020, Vol. 21 Issue 1, p1-12. 12p.

Record details

The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD.

• Authors : Dean J; Medicines Evaluation Unit, Southmoor Road, Manchester, M23 9QZ, UK. .; Panainte C

Subjects: Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/*administration & dosage ; Beclomethasone/Beclomethasone/Beclomethasone/*administration & dosage ; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*administration & dosage

• Source: Respiratory research [Respir Res] 2020 Dec 09; Vol. 21 (1), pp. 323. Date of Electronic Publication: 2020 Dec 09.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium:

Record details

Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study

• Authors : Magnussen, H; Lucas, S; Lapperre, T

Subjects: COPD; Effectiveness; Inhaled corticosteroidsEngland

Record details

Reducing unnecessary chest X-rays, antibiotics and bronchodilators through implementation of the NICE bronchiolitis guideline.

• Authors : Breakell, Richard; Thorndyke, Benjamin; Clennett, Julie

Subjects: BRONCHIOLITIS; INFANT diseases; SECONDARY care (Medicine)ENGLAND

• Source: European Journal of Pediatrics; Jan2018, Vol. 177 Issue 1, p47-51, 5p, 4 Charts

Record details

Effect of maternal asthma on birthweight and neonatal outcome in a British inner-city population.

• Authors : Clark JM; University of Manchester, Division of Human Development, St Mary's Hospital, Manchester, UK.; Hulme E

Subjects: Asthma/Asthma/Asthma/*epidemiology ; Birth Weight/Birth Weight/Birth Weight/*drug effects ; Infant, Small for Gestational Age/Infant, Small for Gestational Age/Infant, Small for Gestational Age/*growth & development

• Source: Paediatric and perinatal epidemiology [Paediatr Perinat Epidemiol] 2007 Mar; Vol. 21 (2), pp. 154-62.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 8709766 Publication Model: Print Cited

Record details

Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data.

• Authors : Whittaker, Hannah R.¹ (AUTHOR) ; Torkpour, Aria² (AUTHOR); Quint, Jennifer¹ (AUTHOR)

• Source: Respiratory Research. 1/18/2024, Vol. 25 Issue 1, p1-12. 12p.

Record details

Medical emergencies in general dental practice in Great Britain. Part 2: Drugs and equipment possessed by GDPs and used in the management of emergencies.

• Authors : Atherton GJ; Orthodontic Department, University Dental Hospital of Manchester.; McCaul JA

Subjects: Emergencies* ; Equipment and Supplies* ; General Practice, Dental*

• Source: British dental journal [Br Dent J] 1999 Feb 13; Vol. 186 (3), pp. 125-30.Publisher: British Dental Journal Country of Publication: England NLM ID: 7513219 Publication Model: Print Cited Medium:

Record details

Changes in prescribing of psychotropic vs some physical health medication in primary care through the COVID-19 pandemic in England: a national-level survey.

• Authors : Waheed, Unaiza¹ (AUTHOR); Stedman, Mike² (AUTHOR); Davies, Mark³ (AUTHOR)

• Source: Journal of Pharmaceutical Policy & Practice. 12/21/2023, Vol. 16 Issue 1, p1-7. 7p.

Record details